Intravenous Thrombolysis Is Associated with Less Disabling Stroke and Lower Mortality in Multiple-Pass Endovascular Thrombectomy.

医学 溶栓 冲程(发动机) 改良兰金量表 内科学 心脏病学 缺血性中风 脑出血 急性中风 外科 倾向得分匹配
作者
Christopher Blair,Leon Edwards,Cecilia Cappelen-Smith,Dennis Cordato,Andrew Cheung,Jason Wenderoth,Alex McQuinn,Nathan W Manning
出处
期刊:Cerebrovascular Diseases [Karger Publishers]
卷期号:50 (2): 156-161 被引量:1
标识
DOI:10.1159/000512105
摘要

Background and purpose The benefit of bridging intravenous thrombolysis (IVT) in acute ischaemic stroke patients eligible for endovascular thrombectomy (EVT) is unclear. This may be particularly relevant where reperfusion is achieved with multiple thrombectomy passes. We aimed to determine the benefit of bridging IVT in first and multiple-pass patients undergoing EVT ≤6 h from stroke onset to groin puncture. Methods We compared 90-day modified Rankin Scale (mRS) outcomes in 187 consecutive patients with large vessel occlusions (LVOs) of the anterior cerebral circulation who underwent EVT ≤6 h from symptom onset and who achieved modified thrombolysis in cerebral ischaemia (mTICI) 2c/3 reperfusion with the first pass to those patients who required multiple passes to achieve reperfusion. The effect of bridging IVT on outcomes was examined. Results Significantly more first-pass patients had favourable (mRS 0-2) 90-day outcomes (68 vs. 42%, p = 0.001). Multivariate analysis showed an association between first-pass reperfusion and favourable outcomes (OR 2.25; 95% CI 1.08-4.68; p = 0.03). IVT provided no additional benefit in first-pass patients (OR 1.17; CI 0.42-3.20; p = 0.76); however, in multiple-pass patients, it reduced the risk of disabling stroke (mRS ≥4) (OR 0.30; CI 0.10-0.88; p = 0.02) and mortality (OR 0.07; CI 0.01-0.36; p = 0.002) at 90 days. Conclusion Bridging IVT may benefit patients with anterior circulation stroke with LVO who qualify for EVT and who require multiple passes to achieve reperfusion.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
穆羊青发布了新的文献求助10
1秒前
淑文发布了新的文献求助10
2秒前
单薄的夜南应助嘻哈采纳,获得10
2秒前
丘比特应助嘻哈采纳,获得10
2秒前
3秒前
酷酷的涵蕾完成签到 ,获得积分10
3秒前
redking发布了新的文献求助10
3秒前
5秒前
6秒前
7秒前
7秒前
HuiJN完成签到 ,获得积分10
7秒前
锤子完成签到,获得积分10
8秒前
在水一方应助lizibelle采纳,获得10
9秒前
hoyden完成签到,获得积分10
9秒前
Stardust发布了新的文献求助10
10秒前
12秒前
momo发布了新的文献求助10
13秒前
13秒前
乐乐应助Mo采纳,获得10
14秒前
14秒前
Liufgui应助Z6kjoA采纳,获得20
14秒前
爆米花应助科研通管家采纳,获得10
16秒前
NexusExplorer应助科研通管家采纳,获得10
16秒前
cangy发布了新的文献求助10
16秒前
英姑应助科研通管家采纳,获得10
16秒前
地表飞猪应助科研通管家采纳,获得10
16秒前
桐桐应助科研通管家采纳,获得10
16秒前
17秒前
Akim应助科研通管家采纳,获得10
17秒前
Orange应助科研通管家采纳,获得10
17秒前
地表飞猪应助科研通管家采纳,获得10
17秒前
科研通AI2S应助科研通管家采纳,获得10
17秒前
酷波er应助科研通管家采纳,获得10
17秒前
地表飞猪应助科研通管家采纳,获得10
17秒前
17秒前
YamDaamCaa应助科研通管家采纳,获得30
17秒前
luo关闭了luo文献求助
18秒前
Jogging完成签到,获得积分10
19秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989334
求助须知:如何正确求助?哪些是违规求助? 3531428
关于积分的说明 11253936
捐赠科研通 3270119
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173